Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The homocysteine pathway encompasses the biochemical reactions whereby the amino acid homocysteine is generated from methionine and then either converted back to methionine by remethylation or irreversibly catabolized to cysteine by transsulfuration. Key enzymes include methionine synthase (remethylation) and cystathionine β-synthase (transsulfuration), which rely on cofactors such as folate, vitamin B12, and vitamin B6. Disruptions in these pathways, resulting in elevated homocysteine (hyperhomocysteinemia), have been strongly associated with an increased risk of cardiovascular disease, neurodegenerative disorders, pregnancy complications, and other systemic conditions.
Lower homocysteine level via enzyme cofactor supplementation (B vitamins)\nEnhance remethylation (folate/B12)\nEnhance transsulfuration (B6)\nMethyl donor supplementation (betaine)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on null.